Shkreli, 32, resigned as CEO on Friday, a day after his arrest on charges that he had engaged in a Ponzi-like scheme. On Monday, KaloBios Pharmaceuticals said Shkreli was “terminated” as CEO and had resigned from the board. Turing did not specify the number of job cuts in a statement.